XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Adjustment
 [3]
Ordinary Shares
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
 [1]
Retained Earnings
Retained Earnings
Cumulative Effect Adjustment
 [3]
Total Amdocs Limited Shareholders' Equity
Total Amdocs Limited Shareholders' Equity
Cumulative Effect Adjustment
 [3]
Non-controlling Interests
 [2]
Balance at Sep. 30, 2017 $ 3,574,070   $ 4,410 $ 3,458,887 $ (4,365,124) $ 18,790 $ 4,457,107   $ 3,574,070    
Balance, Shares at Sep. 30, 2017     144,391                
Comprehensive income:                      
Net income [2] 354,396           354,396   354,396    
Other comprehensive income (loss), net of tax (51,521)         (51,521)     (51,521)    
Comprehensive income 302,875               302,875    
Employee stock options exercised 81,286   $ 24 81,262         81,286    
Employee stock options exercised, Shares     1,800                
Repurchase of shares (419,228)       (419,228)       (419,228)    
Repurchase of shares, Shares     (6,337)                
Cash dividends declared (137,602)           (137,602)   (137,602)    
Issuance of restricted stock, net of forfeitures 2   $ 2           2    
Issuance of restricted stock, net of forfeitures, Shares     323                
Equity-based compensation expense related to employees 47,476     47,476         47,476    
Changes in Noncontrolling interests 43,163                   $ 43,163
Balance at Sep. 30, 2018 3,492,042   $ 4,436 3,587,625 (4,784,352) (32,731) 4,673,901   3,448,879   43,163
Balance, Shares at Sep. 30, 2018     140,177                
Comprehensive income:                      
Net income [2] 479,446           479,446   479,446    
Other comprehensive income (loss), net of tax 30,184         30,184     30,184    
Comprehensive income 509,630               509,630    
Employee stock options exercised 41,498   $ 11 41,487         41,498    
Employee stock options exercised, Shares     874                
Repurchase of shares (398,057)       (398,057)       (398,057)    
Repurchase of shares, Shares     (6,656)                
Cash dividends declared (150,982)           (150,982)   (150,982)    
Issuance of restricted stock, net of forfeitures 5   $ 5           5    
Issuance of restricted stock, net of forfeitures, Shares     378                
Equity-based compensation expense related to employees 38,550     38,550         38,550    
Changes in Noncontrolling interests (654)                   (654)
Balance at Sep. 30, 2019 $ 3,542,466 $ 10,434 $ 4,452 3,667,662 (5,182,409) (2,547) 5,012,799 $ 10,434 3,499,957 $ 10,434 42,509
Balance, Shares at Sep. 30, 2019 134,773   134,773                
Comprehensive income:                      
Net income [2] $ 497,840           497,840   497,840    
Other comprehensive income (loss), net of tax 14,209         14,209     14,209    
Comprehensive income 512,049               512,049    
Employee stock options exercised $ 97,843   $ 24 97,819         97,843    
Employee stock options exercised, Shares 1,871   1,871                
Repurchase of shares $ (360,912)       (360,912)       (360,912)    
Repurchase of shares, Shares (5,668)   (5,668)                
Cash dividends declared $ (168,732)           (168,732)   (168,732)    
Issuance of restricted stock, net of forfeitures 7   $ 7           7    
Issuance of restricted stock, net of forfeitures, Shares     559                
Equity-based compensation expense related to employees 42,434     42,434         42,434    
Balance at Sep. 30, 2020 $ 3,665,155   $ 4,483 $ 3,807,915 $ (5,543,321) $ 11,662 $ 5,341,907   $ 3,622,646   $ 42,509
Balance, Shares at Sep. 30, 2020 131,535   131,535                
[1] As of September 30, 2020, 2019 and 2018, accumulated other comprehensive income (loss) is comprised of unrealized gain (loss) on derivatives, net of tax, of $18,836, $3,945 and $(26,608), unrealized loss on short-term interest-bearing investments, net of tax, of $(2), $0 and $(1,592) and unrealized loss on defined benefit plan, net of tax, of $(7,172), $(6,492) and $(4,531).
[2] In fiscal years 2020, 2019 and 2018, all of the Company’s net income is attributable to Amdocs Limited as the net income attributable to the Non-controlling interests is negligible.
[3] The Cumulative effect adjustments as of October 1, 2018 include an increase of $14,294 to retained earnings due to the impact of adoptions of ASU No. 2014-09 (ASC 606) and decrease of $3,860 to retained earnings due to adoption of ASU No. 2016-16.